Jur Strobos

1.1k total citations
17 papers, 793 citations indexed

About

Jur Strobos is a scholar working on Hematology, Dermatology and Infectious Diseases. According to data from OpenAlex, Jur Strobos has authored 17 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Dermatology and 2 papers in Infectious Diseases. Recurrent topics in Jur Strobos's work include Iron Metabolism and Disorders (5 papers), Facial Rejuvenation and Surgery Techniques (4 papers) and Erythropoietin and Anemia Treatment (4 papers). Jur Strobos is often cited by papers focused on Iron Metabolism and Disorders (5 papers), Facial Rejuvenation and Surgery Techniques (4 papers) and Erythropoietin and Anemia Treatment (4 papers). Jur Strobos collaborates with scholars based in United States, Sweden and Ghana. Jur Strobos's co-authors include Gerald A. Faich, Allen R. Nissenson, Paul A. Seligman, Mark L. Jewell, Rhoda S. Narins, Mark A. Rubin, Joel L. Cohen, Beckie Michael, Vaughn W. Folkert and J. Richard Trout and has published in prestigious journals such as Clinical Infectious Diseases, Kidney International and Journal of Medicinal Chemistry.

In The Last Decade

Jur Strobos

17 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jur Strobos United States 13 458 296 137 114 82 17 793
Annelies E. van Ede Netherlands 10 479 1.0× 344 1.2× 11 0.1× 32 0.3× 39 0.5× 19 1.1k
Joyce Z. Singer United States 10 82 0.2× 61 0.2× 205 1.5× 33 0.3× 143 1.7× 12 798
P. M. Houtman Netherlands 16 173 0.4× 47 0.2× 107 0.8× 59 0.5× 111 1.4× 25 768
Vassilios Perifanis Greece 15 418 0.9× 423 1.4× 15 0.1× 9 0.1× 48 0.6× 55 810
Hasan Tahir United Kingdom 20 602 1.3× 22 0.1× 19 0.1× 152 1.3× 92 1.1× 92 1.5k
Barry Cooper United States 12 505 1.1× 439 1.5× 17 0.1× 9 0.1× 101 1.2× 25 833
Kolitha Basnayake United Kingdom 13 374 0.8× 110 0.4× 233 1.7× 9 0.1× 84 1.0× 18 731
Maher Issa United States 19 182 0.4× 130 0.4× 8 0.1× 163 1.4× 47 0.6× 26 965
Marilyn A. Solsky United States 8 191 0.4× 41 0.1× 28 0.2× 16 0.1× 61 0.7× 9 774
A Marmont Italy 7 338 0.7× 72 0.2× 16 0.1× 17 0.1× 85 1.0× 12 649

Countries citing papers authored by Jur Strobos

Since Specialization
Citations

This map shows the geographic impact of Jur Strobos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jur Strobos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jur Strobos more than expected).

Fields of papers citing papers by Jur Strobos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jur Strobos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jur Strobos. The network helps show where Jur Strobos may publish in the future.

Co-authorship network of co-authors of Jur Strobos

This figure shows the co-authorship network connecting the top 25 collaborators of Jur Strobos. A scholar is included among the top collaborators of Jur Strobos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jur Strobos. Jur Strobos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Deng, Wenlin, Yasuhiro Kimura, Andrea Balogh, et al.. (2015). Mitigation of the Hematopoietic and Gastrointestinal Acute Radiation Syndrome by Octadecenyl Thiophosphate, a Small Molecule Mimic of Lysophosphatidic Acid. Radiation Research. 183(4). 465–475. 31 indexed citations
2.
Patil, Renukadevi, Erzsébet Szabó, James I. Fells, et al.. (2015). Combined Mitigation of the Gastrointestinal and Hematopoietic Acute Radiation Syndromes by an LPA2 Receptor-Specific Nonlipid Agonist. Chemistry & Biology. 22(2). 206–216. 34 indexed citations
3.
Patil, Renukadevi, James I. Fells, Erzsébet Szabó, et al.. (2014). Design and Synthesis of Sulfamoyl Benzoic Acid Analogues with Subnanomolar Agonist Activity Specific to the LPA2 Receptor. Journal of Medicinal Chemistry. 57(16). 7136–7140. 13 indexed citations
4.
Mani, Nina, Jeffrey S. Murray, Roy M. Gulick, et al.. (2012). Novel clinical trial designs for the development of new antiretroviral agents. AIDS. 26(8). 899–907. 12 indexed citations
5.
Bakare, Nyasha, I. Ralph Edwards, Andy Stergachis, et al.. (2011). Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities. PLoS Medicine. 8(7). e1001054–e1001054. 16 indexed citations
6.
Triant, Virginia A., Filip Josephson, Keri N. Althoff, et al.. (2011). Adverse Outcome Analyses of Observational Data: Assessing Cardiovascular Risk in HIV Disease. Clinical Infectious Diseases. 54(3). 408–413. 15 indexed citations
7.
Hamilton, Robert G., Jur Strobos, & N. Franklin Adkinson. (2007). Immunogenicity Studies of Cosmetically Administered Nonanimal-Stabilized Hyaluronic Acid Particles. Dermatologic Surgery. 33. S176–S185. 35 indexed citations
8.
Hamilton, Robert G., Jur Strobos, & N. Franklin Adkinson. (2007). Immunogenicity Studies of Cosmetically Administered Nonanimal-Stabilized Hyaluronic Acid Particles. Dermatologic Surgery. 33(Supplement). S176–S185. 3 indexed citations
9.
Narins, Rhoda S., Mark L. Jewell, Mark A. Rubin, Joel L. Cohen, & Jur Strobos. (2006). Clinical Conference: Management of Rare Events Following Dermal Fillers-Focal Necrosis and Angry Red Bumps. Dermatologic Surgery. 32(3). 426–434. 86 indexed citations
10.
Narins, Rhoda S., Mark L. Jewell, Mark A. Rubin, Joel L. Cohen, & Jur Strobos. (2006). Clinical Conference. Dermatologic Surgery. 32(3). 426–434. 2 indexed citations
11.
Seligman, Paul A., Naomi V. Dahl, Jur Strobos, et al.. (2004). Single‐Dose Pharmacokinetics of Sodium Ferric Gluconate Complex in Iron‐Deficient Subjects. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(5). 574–583. 29 indexed citations
12.
Coyne, Daniel W., Allen R. Nissenson, Steven Fishbane, et al.. (2003). Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients. Kidney International. 63(1). 217–224. 68 indexed citations
13.
Michael, Beckie, Daniel W. Coyne, Steven Fishbane, et al.. (2002). Sodium ferric gluconate complex in hemodialysis patients: Adverse reactions compared to placebo and iron dextran. Kidney International. 61(5). 1830–1839. 146 indexed citations
14.
Nissenson, Allen R., et al.. (1999). Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American clinical trial. American Journal of Kidney Diseases. 33(3). 471–482. 84 indexed citations
15.
Nissenson, Allen R. & Jur Strobos. (1999). Iron deficiency in patients with renal failure. Kidney International. 55. S18–S21. 61 indexed citations
16.
Faich, Gerald A. & Jur Strobos. (1999). Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextrans. American Journal of Kidney Diseases. 33(3). 464–470. 157 indexed citations
17.
Strobos, Jur. (1997). Medical Foods. Clinical Research and Regulatory Affairs. 14(1). 5–13. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026